1
|
Doyle LA: Sarcoma classification: An
update based on the 2013 World Health Organization classification
of tumors of soft tissue and bone. Cancer. 120:1763–1774. 2014.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Mastrangelo G, Coindre JM, Ducimetière F,
Dei Tos AP, Fadda E, Blay JY, Buja A, Fedeli U, Cegolon L, Frasson
A, et al: Incidence of soft tissue sarcoma and beyond: A
population-based prospective study in 3 European regions. Cancer.
118:5339–5348. 2012. View Article : Google Scholar : PubMed/NCBI
|
3
|
Antonescu C: Malignant vascular tumors-an
update. Mod Pathol. 27 (Suppl 1):S30–S38. 2014. View Article : Google Scholar : PubMed/NCBI
|
4
|
Wolov RB, Sato N, Azumi N and Lack EE:
Intra-abdominal ‘angiosarcomatosis’ report of two cases after
pelvic irradiation. Cancer. 67:2275–2279. 1991. View Article : Google Scholar : PubMed/NCBI
|
5
|
Kumar S: Second malignant neoplasms
following radiotherapy. Int J Environ Res Public Health.
9:4744–4759. 2012. View Article : Google Scholar : PubMed/NCBI
|
6
|
Sholl LM, Barletta JA and Hornick JL:
Radiation-associated neoplasia: Clinical, pathological and genomic
correlates. Histopathology. 70:70–80. 2017. View Article : Google Scholar : PubMed/NCBI
|
7
|
Anzalone CL, Cohen PR, Diwan AH and Prieto
VG: Radiation-induced angiosarcoma. Dermatol Online J.
19:22013.PubMed/NCBI
|
8
|
Virtanen A, Pukkala E and Auvinen A:
Incidence of bone and soft tissue sarcoma after radiotherapy: A
cohort study of 295,712 Finnish cancer patients. Int J Cancer.
118:1017–1021. 2006. View Article : Google Scholar : PubMed/NCBI
|
9
|
Virtanen A, Pukkala E and Auvinen A:
Angiosarcoma after radiotherapy: A cohort study of 332,163 Finnish
cancer patients. Br J Cancer. 97:115–117. 2007. View Article : Google Scholar : PubMed/NCBI
|
10
|
Bhojani N, Capitanio U, Suardi N, Jeldres
C, Isbarn H, Shariat SF, Graefen M, Arjane P, Duclos A, Lattouf JB,
et al: The rate of secondary malignancies after radical
prostatectomy versus external beam radiation therapy for localized
prostate cancer: A population-based study on 17,845 patients. Int J
Radiat Oncol Biol Phys. 76:342–348. 2010. View Article : Google Scholar : PubMed/NCBI
|
11
|
Wallis CJ, Mahar AL, Choo R, Herschorn S,
Kodama RT, Shah PS, Danjoux C, Narod SA and Nam RK: Second
malignancies after radiotherapy for prostate cancer: Systematic
review and meta-analysis. BMJ. 352:i8512016. View Article : Google Scholar : PubMed/NCBI
|
12
|
Wang G, Black PC, Skinnider BF, Hayes MM
and Jones EC: Post-radiation epithelioid angiosarcoma of the
urinary bladder and prostate. Can Urol Assoc J. 10:E197–E200. 2016.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Gupta A, Patnaik MM and Naina HV:
Angiosarcoma of the prostate gland following brachytherapy for
prostatic adenocarcinoma. Curr Urol. 8:109–112. 2015. View Article : Google Scholar : PubMed/NCBI
|
14
|
Ojerholm E, Stripp D, Mamtani R, Van
Arsdalen K and Tripp P: Angiosarcoma of the bladder following
prostate radiotherapy. Am J Med. 128:e11–e12. 2015. View Article : Google Scholar : PubMed/NCBI
|
15
|
Chandan VS and Wolsh L: Postirradiation
angiosarcoma of the prostate. Arch Pathol Lab Med. 127:876–878.
2003.PubMed/NCBI
|
16
|
Sakemi M, Sakemi R, Harada M, So S,
Uchiyama D, Morimitsu Y, Kakiuchi S, Ishihara Y, Kubo Y, Matsugaki
S, et al: A case of postirradiation angiosarcoma of the greater
omentum with hemorrhage. Clin J Gastroenterol. 4:302–306. 2011.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Cahan WG, Woodard HQ, et al: Sarcoma
arising in irradiated bone; report of 11 cases. Cancer. 1:3–29.
1948. View Article : Google Scholar : PubMed/NCBI
|
18
|
Wade MA, May FE, Onel K and Allan JM: Does
radiation-induced c-MYC amplification initiate breast oncogenesis?
Mol Cell Oncol. 3:e10109502015. View Article : Google Scholar : PubMed/NCBI
|
19
|
Wade MA, Sunter NJ, Fordham SE, Long A,
Masic D, Russell LJ, Harrison CJ, Rand V, Elstob C, Bown N, et al:
c-MYC is a radiosensitive locus in human breast cells. Oncogene.
34:4985–4994. 2015. View Article : Google Scholar : PubMed/NCBI
|
20
|
Styring E, Seinen J, Dominguez-Valentin M,
Domanski HA, Jönsson M, von Steyern FV, Hoekstra HJ, Suurmeijer AJ
and Nilbert M: Key roles for MYC KIT and RET signaling in secondary
angiosarcomas. Br J Cancer. 111:407–412. 2014. View Article : Google Scholar : PubMed/NCBI
|
21
|
Manner J, Radlwimmer B, Hohenberger P,
Mössinger K, Küffer S, Sauer C, Belharazem D, Zettl A, Coindre JM,
Hallermann C, et al: MYC high level gene amplification is a
distinctive feature of angiosarcomas after irradiation or chronic
lymphedema. Am J Pathol. 176:34–39. 2010. View Article : Google Scholar : PubMed/NCBI
|
22
|
Fraga-Guedes C, André S, Mastropasqua MG,
Botteri E, Toesca A, Rocha RM, Peradze N, Rotmensz N, Viale G,
Veronesi P and Gobbi H: Angiosarcoma and atypical vascular lesions
of the breast: Diagnostic and prognostic role of MYC gene
amplification and protein expression. Breast Cancer Res Treat.
151:131–140. 2015. View Article : Google Scholar : PubMed/NCBI
|
23
|
Fernandez AP, Sun Y, Tubbs RR, Goldblum JR
and Billings SD: FISH for MYC amplification and anti-MYC
immunohistochemistry: Useful diagnostic tools in the assessment of
secondary angiosarcoma and atypical vascular proliferations. J
Cutan Pathol. 39:234–242. 2012. View Article : Google Scholar : PubMed/NCBI
|
24
|
Laé M, Lebel A, Hamel-Viard F, Asselain B,
Trassard M, Sastre X and Kirova YM: Can c-myc amplification
reliably discriminate postradiation from primary angiosarcoma of
the breast? Cancer Radiother. 19:168–174. 2015. View Article : Google Scholar : PubMed/NCBI
|
25
|
Mentzel T, Schildhaus HU, Palmedo G,
Büttner R and Kutzner H: Postradiation cutaneous angiosarcoma after
treatment of breast carcinoma is characterized by MYC amplification
in contrast to atypical vascular lesions after radiotherapy and
control cases: clinicopathological, immunohistochemical and
molecular analysis of 66 cases. Mod Pathol. 25:75–85. 2012.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Mark RJ, Poen J, Tran LM, Fu YS, Selch MT
and Parker RG: Postirradiation sarcomas. A single-institution study
and review of the literature. Cancer. 73:2653–2662. 1994.
|